R2 Semiconductor Announces Two Important Updates in Intel Patent Infringement Case
German Court Denies Intel’s Attempt to Stay Injunctions That Prevent it from Using R2’s Patented Technology R2 Files Patent Infringement Lawsuits against Amazon... Read more.
Fisker Announces Receipt of Financing Commitment of Up to $150 Million and Provides Business Update
Funding will be organized in four tranches and is being provided by the holder of the company’s 2025-dated convertible notes. Fisker is in continuing negotiations... Read more.
SRA Consulting and Bluejaÿ AI Forge Strategic Partnership to Revolutionize Risk Management in the Banking Sector
Combining Deep Risk Management Expertise with Advanced AI Forecasting to Transform Operational Resilience RICHMOND, Va.–(BUSINESS WIRE)–#AI–In... Read more.
Constellation Offers Nation’s First Corporate Green Bond for Nuclear Energy
Green financing instrument reinforces role of clean, reliable nuclear energy in achieving sustainability goals BALTIMORE–(BUSINESS WIRE)–Constellation... Read more.
DataLink Announces New Medical Chart Review Solutions to Support Risk Adjustment and HEDIS Quality Performance
TAMPA, Fla.–(BUSINESS WIRE)–DataLink, a leading provider of data-driven solutions for high-quality, value-based care, today announced that they’re... Read more.
United States Steel Corporation Provides First Quarter 2024 Guidance
PITTSBURGH–(BUSINESS WIRE)–United States Steel Corporation (NYSE: X) today provided first quarter 2024 adjusted net earnings per diluted share guidance... Read more.
M-Files Named Among KMWorld’s 2024 100 Companies That Matter in Knowledge Management
M-Files Platform Recognized as a Pioneering Solution, Driving Advancements in Information Management AUSTIN, Texas–(BUSINESS WIRE)–#awardwin—M-Files,... Read more.
Neupulse Secures Funding to Advance World’s First Wearable Device to Tackle Tourettes Syndrome
NOTTINGHAM, England–(BUSINESS WIRE)–Neupulse has secured funding to advance the world’s first wearable device aimed at tackling Tourettes Syndrome... Read more.
Eureka Therapeutics Advances ARYA-3 Clinical Trial to Phase II for Treatment of Liver Cancer Using GPC3-Targeting ARTEMIS® T-cell Therapy
EMERYVILLE, Calif.–(BUSINESS WIRE)–#Tcelltherapy–Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T-cell therapies... Read more.
Jadex Inc. Recognized as U.S. Best-in-Class Employer by Gallagher
Gallagher’s Best-in-Class Benchmarking Analysis Identifies U.S. Organizations That Excel in Optimizing Employee and Organizational Wellbeing GREER, S.C.–(BUSINESS... Read more.